BIOMAT Database Logo BIOMAT Database Logo

[Cerebrospinal fluid metabolism of biogenic amines in Huntington chorea]. 1976

C Loeb, and G Roccatagliata, and C Albano, and G Lamedica, and G Abbruzzese, and S Canini

CSF metabolites of dopamine (HVA), norepinephrine (MHPG) and serotonine (5HIAA) in 9 patients affected by Huntington's Chorea before and after therapy with phenotiazine derivatives (Fluphenazine) have been studied. A close relationship seems to exist between therapeutical results and CSF HVA modifications: improvement of choreatic movements is associated with marked increase in CSF HVA values. Biochemical bases of Huntington's Chorea are discussed.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009638 Norepinephrine Precursor of epinephrine that is secreted by the ADRENAL MEDULLA and is a widespread central and autonomic neurotransmitter. Norepinephrine is the principal transmitter of most postganglionic sympathetic fibers, and of the diffuse projection system in the brain that arises from the LOCUS CERULEUS. It is also found in plants and is used pharmacologically as a sympathomimetic. Levarterenol,Levonorepinephrine,Noradrenaline,Arterenol,Levonor,Levophed,Levophed Bitartrate,Noradrenaline Bitartrate,Noradrénaline tartrate renaudin,Norepinephrin d-Tartrate (1:1),Norepinephrine Bitartrate,Norepinephrine Hydrochloride,Norepinephrine Hydrochloride, (+)-Isomer,Norepinephrine Hydrochloride, (+,-)-Isomer,Norepinephrine d-Tartrate (1:1),Norepinephrine l-Tartrate (1:1),Norepinephrine l-Tartrate (1:1), (+,-)-Isomer,Norepinephrine l-Tartrate (1:1), Monohydrate,Norepinephrine l-Tartrate (1:1), Monohydrate, (+)-Isomer,Norepinephrine l-Tartrate (1:2),Norepinephrine l-Tartrate, (+)-Isomer,Norepinephrine, (+)-Isomer,Norepinephrine, (+,-)-Isomer
D004298 Dopamine One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action. Hydroxytyramine,3,4-Dihydroxyphenethylamine,4-(2-Aminoethyl)-1,2-benzenediol,Dopamine Hydrochloride,Intropin,3,4 Dihydroxyphenethylamine,Hydrochloride, Dopamine
D005260 Female Females
D005476 Fluphenazine A phenothiazine used in the treatment of PSYCHOSES. Its properties and uses are generally similar to those of CHLORPROMAZINE. Flufenazin,Fluphenazine Hydrochloride,Lyogen,Prolixin,Hydrochloride, Fluphenazine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006816 Huntington Disease A familial disorder inherited as an autosomal dominant trait and characterized by the onset of progressive CHOREA and DEMENTIA in the fourth or fifth decade of life. Common initial manifestations include paranoia; poor impulse control; DEPRESSION; HALLUCINATIONS; and DELUSIONS. Eventually intellectual impairment; loss of fine motor control; ATHETOSIS; and diffuse chorea involving axial and limb musculature develops, leading to a vegetative state within 10-15 years of disease onset. The juvenile variant has a more fulminant course including SEIZURES; ATAXIA; dementia; and chorea. (From Adams et al., Principles of Neurology, 6th ed, pp1060-4) Huntington Chorea,Juvenile Huntington Disease,Akinetic-Rigid Variant of Huntington Disease,Chorea, Chronic Progressive Hereditary (Huntington),Chronic Progressive Hereditary Chorea (Huntington),Huntington Chronic Progressive Hereditary Chorea,Huntington Disease, Akinetic-Rigid Variant,Huntington Disease, Juvenile,Huntington Disease, Juvenile-Onset,Huntington Disease, Late Onset,Huntington's Chorea,Huntington's Disease,Juvenile-Onset Huntington Disease,Late-Onset Huntington Disease,Progressive Chorea, Chronic Hereditary (Huntington),Progressive Chorea, Hereditary, Chronic (Huntington),Akinetic Rigid Variant of Huntington Disease,Chorea, Huntington,Chorea, Huntington's,Huntington Disease, Akinetic Rigid Variant,Huntington Disease, Juvenile Onset,Huntington Disease, Late-Onset,Juvenile Onset Huntington Disease,Late Onset Huntington Disease
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

C Loeb, and G Roccatagliata, and C Albano, and G Lamedica, and G Abbruzzese, and S Canini
Cerebrospinal fluid biogenic amines and biopterin in Rett syndrome.
January 1989, Annals of neurology,
C Loeb, and G Roccatagliata, and C Albano, and G Lamedica, and G Abbruzzese, and S Canini
Cyclic AMP in cerebrospinal fluid: accumulaiton following probenecid and biogenic amines.
February 1975, Experimental neurology,
C Loeb, and G Roccatagliata, and C Albano, and G Lamedica, and G Abbruzzese, and S Canini
Cerebrospinal fluid and urinary biogenic amines in depressed patients and healthy controls.
August 1988, Archives of general psychiatry,
C Loeb, and G Roccatagliata, and C Albano, and G Lamedica, and G Abbruzzese, and S Canini
Cerebrospinal fluid studies in the Rett syndrome: biogenic amines and beta-endorphins.
January 1990, Brain & development,
C Loeb, and G Roccatagliata, and C Albano, and G Lamedica, and G Abbruzzese, and S Canini
Amino acids and biogenic amines in cerebrospinal fluid of patients with Parkinson's disease.
August 2003, Neurochemical research,
C Loeb, and G Roccatagliata, and C Albano, and G Lamedica, and G Abbruzzese, and S Canini
Cerebrospinal fluid biogenic amines depletion and brain atrophy in adult patients with phenylketonuria.
May 2019, Journal of inherited metabolic disease,
C Loeb, and G Roccatagliata, and C Albano, and G Lamedica, and G Abbruzzese, and S Canini
Cerebrospinal fluid biogenic amines in obsessive compulsive disorder, Tourette's syndrome, and healthy controls.
February 1995, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,
C Loeb, and G Roccatagliata, and C Albano, and G Lamedica, and G Abbruzzese, and S Canini
Biogenic amines in cerebrospinal fluid and plasma of patients with dementia of Alzheimer type.
January 1987, Functional neurology,
C Loeb, and G Roccatagliata, and C Albano, and G Lamedica, and G Abbruzzese, and S Canini
Pulmonary metabolism of biogenic amines.
April 1997, Comprehensive therapy,
C Loeb, and G Roccatagliata, and C Albano, and G Lamedica, and G Abbruzzese, and S Canini
[Familial amyotrophic lateral sclerosis associated with Huntington chorea with increased aspartate level in the cerebrospinal fluid].
January 1992, Revue neurologique,
Copied contents to your clipboard!